Canine Lymphoma Treatment: Understanding Your Options

Canine lymphoma treatment is a complex and often emotional journey for pet owners. The good news is that there are several treatment options available, each with its own pros and cons.

Chemotherapy is a common treatment for canine lymphoma, and it can be used alone or in combination with other therapies. According to research, chemotherapy can be effective in inducing remission in up to 70% of dogs with lymphoma.

The type of chemotherapy used will depend on the stage and type of lymphoma, as well as the dog's overall health. For example, a study found that dogs with stage II lymphoma responded better to a combination of doxorubicin and cyclophosphamide than to either drug alone.

In addition to chemotherapy, radiation therapy can also be used to treat canine lymphoma. Radiation can be used to target specific areas of the body, such as the spleen or lymph nodes.

Medications are a crucial part of canine lymphoma treatment.

L-asparaginase, an injectable chemotherapy drug, is given under the skin and can be combined with CCNU, an oral drug. Treatments are repeated every 3 weeks, with an 80-90% chance of remission and responses typically lasting about 3 treatments.

The estimated cost for L-asparaginase and CCNU is $2,000 total for the first 2 treatments, and $600-$700 per treatment thereafter.

Prednisone, an anti-cancer treatment, can also be prescribed to help dogs feel better and maintain their appetite and energy. The benefit of Prednisone typically lasts only a few weeks to months once a dog is out of remission.

For another approach, see: Prednisone Canine Lymphoma

L-asparaginase (L-Spar) is injected under the skin and is usually given with the first 1-2 treatments only.

This combination treatment is repeated every 3 weeks, with an estimated cost per cycle ranging from $2,000 to $2,200. The estimated cost for the first 2 treatments is $2,000, and each subsequent treatment costs between $600-$700.

There's a good chance of remission with this treatment, with an 80-90% chance of achieving it. However, responses typically last about 3 treatments, but can be longer in some cases.

Additional reading: Cost to Treat Lymphoma in Dogs

Prednisone is an anti-cancer treatment for some dogs with lymphoma, and it can also help them feel better and maintain their appetite and energy. This benefit typically doesn't last more than a few weeks to months once a dog is out of remission.

No specific monitoring is required for dogs on prednisone alone. It's estimated that the cost of prednisone per month is $20-$30.

Prednisone can be combined with Laverdia, an oral chemotherapy drug given twice weekly. Rechecks are required every 2-4 weeks when taking this combination.

The estimated cost per month for prednisone combined with Laverdia is $350-$550.

For your interest: Canine Diabetes Treatment Cost

Tanovea is the first fully FDA-approved drug for canine lymphoma, specifically for the treatment of lymphoma without specifying immunophenotype, anatomic site, stage/substage, or degree of pretreatment.

Tanovea is given as a 30-minute IV infusion once every 3 weeks at a dose of 1 mg/kg for up to 5 consecutive doses.

Common side effects of Tanovea include gastrointestinal and hematologic changes, similar to those seen with other chemotherapy agents.

Incremental dose reductions or dose delays may be used to manage adverse reactions.

A cumulative dermatopathy is a specific toxicity associated with Tanovea, characterized by local superficial erythema and pruritus, most often in the periauricular region, dorsum, and inguinal region.

This dermatopathy typically resolves with drug discontinuation and supportive therapies.

Pulmonary fibrosis is a rare but serious complication of Tanovea, occurring in a small number of dogs (~4%) months after study completion, while in remission.

Careful monitoring with thoracic radiographs is recommended to detect this complication early.

As we dive into the world of canine lymphoma treatment, it's essential to stay up-to-date on the latest news and updates.

New research has shown that chemotherapy is still a viable option for treating canine lymphoma, with some studies indicating that it can improve survival rates by up to 50%.

Recent studies have also highlighted the importance of early detection, with one study finding that dogs diagnosed with lymphoma at an early stage have a significantly better prognosis.

The use of immunotherapy is gaining traction, with some veterinarians reporting promising results in clinical trials.

Chemotherapy is typically the first line of treatment for canine lymphoma, and it's often used in combination with other therapies to maximize its effectiveness.

Researchers are also exploring the use of targeted therapy, which involves using medications that specifically target the cancer cells.

The cost of treatment can be a significant concern for pet owners, but many veterinarians offer financing options or payment plans to make treatment more accessible.

Clinical trials are underway to evaluate the safety and efficacy of new treatments, including a study on the use of a specific medication to target cancer cells.

When handling your dog's waste during chemotherapy, take care to avoid contact with urine and faeces, as chemotherapy agents can be excreted in these.

Pregnant women should avoid contact with the pet's waste following chemotherapy, as a precaution.

You will be advised of specific precautions to take when your dog is undergoing chemotherapy, so be sure to follow these instructions carefully.

Care must be taken to prevent exposure to the chemotherapy agents that can be present in your dog's waste.

Broaden your view: Dog Cancer Lump on Leg

Standard treatment for canine lymphoma typically involves a 16-week protocol of doxorubicin-based combination chemotherapy, also known as CHOP.

This protocol is broken down into four 4-week cycles, followed by regular monitoring every 4 to 8 weeks. However, T-cell lymphoma may require a modified protocol that substitutes doxorubicin with alkylating agents.

In some cases, less intensive alternatives to standard CHOP-based chemotherapy may be chosen, such as single-agent doxorubicin or lomustine (CCNU) with or without L-asparaginase and prednisone for palliative care.

Note that due to concerns for heart muscle toxicity, doxorubicin may be substituted with mitoxantrone in some cases.

If this caught your attention, see: Doxorubicin for Dogs with Lymphoma